Insigneo Institute - Driving innovative research at the interface of healthcare, engineering and science to transform the future of healthcare technology.
Have you registered for the Insigneo Showcase yet?
💡 Join us on 18 June to see how our innovative research at the interface of healthcare, engineering and science is transforming healthcare technology.
Check out our full programme of speakers here: https://t.co/Rzq3AWG4HG
Get to know @cherise_go, Asst Prof at @sheffielduni 🇬🇧. She’s an ELLIS Scholar in the ELLIS Unit Manchester and the ELLIS Program Robust Machine Learning. Her area of research is in AI and machine learning for healthcare.
#WomenInELLIS
When people with diabetes and high blood pressure develop chronic kidney disease, determining which condition is damaging the kidneys often requires an invasive biopsy.
To evaluate whether this distinction could be made without biopsy, researchers extended a whole-body vascular model with a detailed renal network and used virtual clinical trials to identify cardiovascular biomarkers that differentiate diabetic from hypertensive kidney disease. Key findings included:
🔹 The pulsatility index measured in the main renal artery showed strong diagnostic discrimination, correctly distinguishing diabetic kidney disease from hypertensive kidney disease in most cases.
🔹 Combining pulsatility index with resistive index substantially improved classification performance.
🔹 A three-biomarker combination based on mean, systolic, and diastolic blood flow rates achieved the highest predictive accuracy.
If validated in clinical trials, these biomarker strategies could enable clinicians to identify the cause of kidney damage non-invasively.
𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: https://t.co/f4xreTWAEf
𝗦𝘁𝘂𝗱𝘆: A Virtual Trial to Identify Cardiovascular Biomarkers for Differentiating Diabetic and Hypertensive Kidney Disease
𝗔𝘂𝘁𝗵𝗼𝗿𝘀: Ning Wang, @oneiseitwopi, @ivanbenvan, and Alberto Marzo
@sheffielduni@insigneo@SheffUniEng@SheffMechEng@shefunihealth
𝗦𝘂𝗯𝗺𝗶𝘁 𝘆𝗼𝘂𝗿 𝗺𝗮𝗻𝘂𝘀𝗰𝗿𝗶𝗽𝘁: https://t.co/Gyz8DNnMJO
Insigneo member Prof Pinaki Bhattacharya on his vision of how in silico medicine can become an integral part of healthcare and building collaborative networks for a digital health innovation ecosystem in this VPH_Society
Executive Committee interview series.
🎙️New interview in the #VPH Executive Committee Series
Prof. Pinaki Bhattacharya on collaboration, musculoskeletal modelling, regulation & the future of #InSilicoMedicine.
👉 Read more: https://t.co/qDu4QF5zEp
Podcast - Wearable device technology and the future of patient assessment
In this episode of the Heart podcast, Digital Media Editor Professor James Rudd is joined by Dr Paul Morris and Dr Gareth Williams from the University of Sheffield. They discuss what wearable devices are, the technology that powers them, and how they will impact the future of cardiology patient care.
Podcast: https://t.co/JezDa9cPzp
Paper: https://t.co/s4iPbaoKzR
⏰ Deadline Approaching! ⏰
📅 15 January 2026
Under two weeks to apply for our fully funded PhD project “Engineering an in vitro human embryo implantation platform to study pathologies arising in early pregnancy” at @sheffielduni. #development#endometrium#materialsscience
🔥 First Sano Seminar 2026 – NEXT WEEK!
Paweł Sobkowicz analyzes 2025 Nobel Econ Prize: How tech drives growth 👉 Mokyr, Aghion, Howitt
📅 Jan 12, 14:00 CET | Zoom
Register: https://t.co/g2ZzLgrOzP
#SanoSeminar#NobelPrize#TechInnovation
🧠 Join us this Monday (Dec 15, 14:00 CEST) for a #SanoSeminar with Monika Pytlarz from Sano’s Computational #Neuroscience Team
Talk: Translating AI into Clinical Practice: Lessons from the Children’s Hospital of PhiladelphiavOnline → https://t.co/NoUIvD2D2g
#MedicalAI#Research
Tomorrow at #BMVC2025 I will chair the Doctoral Consortium from 10:00–13:00 in the Goodwin Room, Cutlers’ Hall (S1 1HG) 🎓@sheffielduni@shefcompsci@BMVCconf
Join us to hear talented PhD candidates from around the world, all in the stunning, historic Cutlers’ Hall. ✨
🚀 Shaping the Future of AI + Bio
Excited to be invited as one of the top 25 scientists at the UKRI BBSRC AIBIO-UK sandpit on AI + Biosciences.
Presented work on Explainable AI for Multimodalities and loved connecting with brilliant researchers across the UK.
#AI#BIO#ukri
2 Days to Go!
In Silico Medicine & Beyond: A New VPH Chapter is almost here!
In just two days, our community will gather for a milestone event exploring how #DigitalTwins, #AI, and simulation are transforming healthcare.
We’re honoured to welcome an incredible lineup of speakers, each bringing a unique lens to the future of in silico medicine:
Prof. Liesbet Geris (VPH Director) – presenting a forward-looking vision for VPH and #insilicomedicine over the next decade
· Dr Eric Vibert, MD, PhD (Université Paris-Saclay / INSERM) – on digital twins in liver surgery and how technology is transforming the operating room
· Tina Morrison (EQTY Lab) – on regulatory innovation and trust as enablers of responsible adoption
· Steven Bourke (PersonalPulse) – on the value of mutual creation with patients
Together, they’ll explore how science, policy, and clinical practice can work hand-in-hand to bring in silico medicine from research to real-world impact.
📅 This Wednesday, 19 November 2025
🔗 Register https://t.co/1QwMIU0Qrh
Let’s shape the next chapter of in silico medicine, together.